At Pfizer, they apply science and their global resources to bring therapies to people that extend and significantly improve their lives. They strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products.
Their global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time.
Consistent with their responsibility as one of the world’s premier innovative biopharmaceutical companies, they collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world.
Their R&D Priorities and Strategy
- Delivering a pipeline of highly differentiated medicines and vaccines where they have a unique opportunity to bring the most important new therapies to patients in need
- Advancing their capabilities that can position them for long-term R&D leadership
- Advancing new models for partnerships with creativity, flexibility and urgency to deliver innovation to patients as quickly as possible.
Pfizer Manufacturing Belgium, the largest production and packaging site of Pfizer worldwide, has now joined the CESPE Innovation cluster. The site has an extensive manufacturing setup with a range of formulation booths, filling lines, automatic inspection lines, packaging lines, freeze driers, and lab facilities. With their clinical pilot plant and experimental plant Pfizer Puurs is also known as a Launch Site within the Global Pfizer network, providing them the ability to quickly scale-up to commercial manufacturing of a new product.
OTHER INDUSTRIAL MEMBERS
Other research groups